<?xml version="1.0" ?><!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st June 2018//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_180601.dtd"><PubmedArticleSet><PubmedArticle>    <MedlineCitation Status="In-Data-Review" Owner="NLM">        <PMID Version="1">30318471</PMID>        <DateRevised>            <Year>2018</Year>            <Month>11</Month>            <Day>06</Day>        </DateRevised>        <Article PubModel="Print-Electronic">            <Journal>                <ISSN IssnType="Electronic">1879-2561</ISSN>                <JournalIssue CitedMedium="Internet">                    <Volume>1870</Volume>                    <Issue>2</Issue>                    <PubDate>                        <Year>2018</Year>                        <Month>Dec</Month>                    </PubDate>                </JournalIssue>                <Title>Biochimica et biophysica acta. Reviews on cancer</Title>                <ISOAbbreviation>Biochim Biophys Acta Rev Cancer</ISOAbbreviation>            </Journal>            <ArticleTitle>Ubiquitination and SUMOylation in the chronic inflammatory tumor microenvironment.</ArticleTitle>            <Pagination>                <MedlinePgn>165-175</MedlinePgn>            </Pagination>            <ELocationID EIdType="pii" ValidYN="Y">S0304-419X(18)30114-8</ELocationID>            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.bbcan.2018.08.002</ELocationID>            <Abstract>                <AbstractText>Cells and soluble mediators of the innate and adaptive immune systems are fundamental components of the tumor microenvironment. Nuclear factors, e.g. transcription factors (TFs) and oncoproteins/cancer suppressors, play important roles in controlling cytokine functions leading to the development, maintenance and metastasis of cancers. Studies focusing on the regulators of the pro-tumorigenic microenvironment are particularly pertinent to early diagnosis and potential development of targeted cancer therapeutics. This review is motivated by new insights into the molecular dynamics of ubiquitination and SUMOylation, which post-translationally modify tumor suppressor TFs, leading to initiation and progression of various cancers like prostate, colorectal, liver and breast cancers. These modification pathways are differentially modulated under various stimuli or stresses in order to sustain the oncogenic potentials. We deliberate on the vicious cycle of infection and chronic inflammation-driven processes of ubiquitination and SUMOylation, resulting in the imbalance in cytokine profiles in the pro-tumorigenic microenvironment.</AbstractText>                <CopyrightInformation>Copyright Â© 2018 The Authors. Published by Elsevier B.V. All rights reserved.</CopyrightInformation>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Chang</LastName>                    <ForeName>Shu Chun</ForeName>                    <Initials>SC</Initials>                    <AffiliationInfo>                        <Affiliation>The Ph.D. Program for Translational Medicine, College for Medical Science and Technology, Taipei Medical University, Taiwan. Electronic address: sc.chang@tmu.edu.tw.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Ding</LastName>                    <ForeName>Jeak Ling</ForeName>                    <Initials>JL</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Biological Sciences, National University of Singapore, Singapore, 117543, Singapore. Electronic address: dbsdjl@nus.edu.sg.</Affiliation>                    </AffiliationInfo>                </Author>            </AuthorList>            <Language>eng</Language>            <PublicationTypeList>                <PublicationType UI="D016428">Journal Article</PublicationType>                <PublicationType UI="D016454">Review</PublicationType>            </PublicationTypeList>            <ArticleDate DateType="Electronic">                <Year>2018</Year>                <Month>08</Month>                <Day>21</Day>            </ArticleDate>        </Article>        <MedlineJournalInfo>            <Country>Netherlands</Country>            <MedlineTA>Biochim Biophys Acta Rev Cancer</MedlineTA>            <NlmUniqueID>9806362</NlmUniqueID>            <ISSNLinking>0304-419X</ISSNLinking>        </MedlineJournalInfo>        <KeywordList Owner="NOTNLM">            <Keyword MajorTopicYN="N">Cytokine profile</Keyword>            <Keyword MajorTopicYN="N">Inflammation-associated cancer</Keyword>            <Keyword MajorTopicYN="N">Small ubiquitin-like modifier (SUMO)</Keyword>            <Keyword MajorTopicYN="N">Transcription factors</Keyword>            <Keyword MajorTopicYN="N">Tumor microenvironment</Keyword>            <Keyword MajorTopicYN="N">Ubiquitin-proteasome system (UPS)</Keyword>        </KeywordList>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="received">                <Year>2018</Year>                <Month>07</Month>                <Day>07</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="revised">                <Year>2018</Year>                <Month>08</Month>                <Day>10</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="accepted">                <Year>2018</Year>                <Month>08</Month>                <Day>15</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="pubmed">                <Year>2018</Year>                <Month>10</Month>                <Day>16</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>2018</Year>                <Month>10</Month>                <Day>16</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="entrez">                <Year>2018</Year>                <Month>10</Month>                <Day>16</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>ppublish</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">30318471</ArticleId>            <ArticleId IdType="pii">S0304-419X(18)30114-8</ArticleId>            <ArticleId IdType="doi">10.1016/j.bbcan.2018.08.002</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle></PubmedArticleSet>